WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver
An incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered in daily practice, sometimes leading to unnecessary, invasive and potentially harmful follow-up investigations. The clinical presentation and...
Saved in:
Published in | Cancers Vol. 16; no. 16; p. 2908 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
21.08.2024
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 2072-6694 2072-6694 |
DOI | 10.3390/cancers16162908 |
Cover
Loading…
Abstract | An incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered in daily practice, sometimes leading to unnecessary, invasive and potentially harmful follow-up investigations. The clinical presentation and the imaging aspects play an important role in deciding if, and what further evaluation, is needed. In low-risk patients (i.e., without a history of malignant or chronic liver disease or related symptoms), especially in those younger than 40 years old, more than 95% of IFLLs are likely benign. Shear Wave liver Elastography (SWE) of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on B-mode ultrasound of a benign lesion (e.g., simple cyst, calcification, focal fatty change, typical hemangioma), no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs, since it has a similar accuracy to contrast-enhanced (CE)-MRI. On CEUS, hypoenhancement of a lesion in the late vascular phase is characteristic for malignancy. CE-CT should be avoided for characterizing probable benign FLL and reserved for staging once a lesion is proven malignant. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. US-guided biopsy should be considered in those with unresectable malignant lesions, particularly if the diagnosis remains unclear, or when a specific tissue diagnosis is needed. |
---|---|
AbstractList | This review paper deals with incidentally found focal liver lesions (IFLLs) in otherwise healthy subjects, which is a frequent occurrence in daily practice. The clinical presentation and the imaging aspects play an important role in deciding whether and what further evaluation is required. In low-risk patients (i.e., those without a history of malignant or chronic liver disease or related symptoms, younger than 40 years old), more than 95% of IFLLs are benign. Shear Wave liver Elastography of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on a B-mode ultrasound of a benign lesion, no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. An incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered in daily practice, sometimes leading to unnecessary, invasive and potentially harmful follow-up investigations. The clinical presentation and the imaging aspects play an important role in deciding if, and what further evaluation, is needed. In low-risk patients (i.e., without a history of malignant or chronic liver disease or related symptoms), especially in those younger than 40 years old, more than 95% of IFLLs are likely benign. Shear Wave liver Elastography (SWE) of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on B-mode ultrasound of a benign lesion (e.g., simple cyst, calcification, focal fatty change, typical hemangioma), no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs, since it has a similar accuracy to contrast-enhanced (CE)-MRI. On CEUS, hypoenhancement of a lesion in the late vascular phase is characteristic for malignancy. CE-CT should be avoided for characterizing probable benign FLL and reserved for staging once a lesion is proven malignant. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. US-guided biopsy should be considered in those with unresectable malignant lesions, particularly if the diagnosis remains unclear, or when a specific tissue diagnosis is needed. Simple SummaryThis review paper deals with incidentally found focal liver lesions (IFLLs) in otherwise healthy subjects, which is a frequent occurrence in daily practice. The clinical presentation and the imaging aspects play an important role in deciding whether and what further evaluation is required. In low-risk patients (i.e., those without a history of malignant or chronic liver disease or related symptoms, younger than 40 years old), more than 95% of IFLLs are benign. Shear Wave liver Elastography of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on a B-mode ultrasound of a benign lesion, no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy.AbstractAn incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered in daily practice, sometimes leading to unnecessary, invasive and potentially harmful follow-up investigations. The clinical presentation and the imaging aspects play an important role in deciding if, and what further evaluation, is needed. In low-risk patients (i.e., without a history of malignant or chronic liver disease or related symptoms), especially in those younger than 40 years old, more than 95% of IFLLs are likely benign. Shear Wave liver Elastography (SWE) of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on B-mode ultrasound of a benign lesion (e.g., simple cyst, calcification, focal fatty change, typical hemangioma), no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs, since it has a similar accuracy to contrast-enhanced (CE)-MRI. On CEUS, hypoenhancement of a lesion in the late vascular phase is characteristic for malignancy. CE-CT should be avoided for characterizing probable benign FLL and reserved for staging once a lesion is proven malignant. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. US-guided biopsy should be considered in those with unresectable malignant lesions, particularly if the diagnosis remains unclear, or when a specific tissue diagnosis is needed. An incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered in daily practice, sometimes leading to unnecessary, invasive and potentially harmful follow-up investigations. The clinical presentation and the imaging aspects play an important role in deciding if, and what further evaluation, is needed. In low-risk patients (i.e., without a history of malignant or chronic liver disease or related symptoms), especially in those younger than 40 years old, more than 95% of IFLLs are likely benign. Shear Wave liver Elastography (SWE) of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on B-mode ultrasound of a benign lesion (e.g., simple cyst, calcification, focal fatty change, typical hemangioma), no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs, since it has a similar accuracy to contrast-enhanced (CE)-MRI. On CEUS, hypoenhancement of a lesion in the late vascular phase is characteristic for malignancy. CE-CT should be avoided for characterizing probable benign FLL and reserved for staging once a lesion is proven malignant. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. US-guided biopsy should be considered in those with unresectable malignant lesions, particularly if the diagnosis remains unclear, or when a specific tissue diagnosis is needed.An incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered in daily practice, sometimes leading to unnecessary, invasive and potentially harmful follow-up investigations. The clinical presentation and the imaging aspects play an important role in deciding if, and what further evaluation, is needed. In low-risk patients (i.e., without a history of malignant or chronic liver disease or related symptoms), especially in those younger than 40 years old, more than 95% of IFLLs are likely benign. Shear Wave liver Elastography (SWE) of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on B-mode ultrasound of a benign lesion (e.g., simple cyst, calcification, focal fatty change, typical hemangioma), no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs, since it has a similar accuracy to contrast-enhanced (CE)-MRI. On CEUS, hypoenhancement of a lesion in the late vascular phase is characteristic for malignancy. CE-CT should be avoided for characterizing probable benign FLL and reserved for staging once a lesion is proven malignant. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. US-guided biopsy should be considered in those with unresectable malignant lesions, particularly if the diagnosis remains unclear, or when a specific tissue diagnosis is needed. This review paper deals with incidentally found focal liver lesions (IFLLs) in otherwise healthy subjects, which is a frequent occurrence in daily practice. The clinical presentation and the imaging aspects play an important role in deciding whether and what further evaluation is required. In low-risk patients (i.e., those without a history of malignant or chronic liver disease or related symptoms, younger than 40 years old), more than 95% of IFLLs are benign. Shear Wave liver Elastography of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on a B-mode ultrasound of a benign lesion, no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. An incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered in daily practice, sometimes leading to unnecessary, invasive and potentially harmful follow-up investigations. The clinical presentation and the imaging aspects play an important role in deciding if, and what further evaluation, is needed. In low-risk patients (i.e., without a history of malignant or chronic liver disease or related symptoms), especially in those younger than 40 years old, more than 95% of IFLLs are likely benign. Shear Wave liver Elastography (SWE) of the surrounding liver parenchyma should be considered to exclude liver cirrhosis and for further risk stratification. If an IFLL in a low-risk patient has a typical appearance on B-mode ultrasound of a benign lesion (e.g., simple cyst, calcification, focal fatty change, typical hemangioma), no further imaging is needed. Contrast-Enhanced Ultrasound (CEUS) should be considered as the first-line contrast imaging modality to differentiate benign from malignant IFLLs, since it has a similar accuracy to contrast-enhanced (CE)-MRI. On CEUS, hypoenhancement of a lesion in the late vascular phase is characteristic for malignancy. CE-CT should be avoided for characterizing probable benign FLL and reserved for staging once a lesion is proven malignant. In high-risk patients (i.e., with chronic liver disease or an oncological history), each IFLL should initially be considered as potentially malignant, and every effort should be made to confirm or exclude malignancy. US-guided biopsy should be considered in those with unresectable malignant lesions, particularly if the diagnosis remains unclear, or when a specific tissue diagnosis is needed. |
Audience | Academic |
Author | Dong, Yi Nürnberg, Dieter Sporea, Ioan Petry, Marieke Möller, Kathleen Dietrich, Christoph F. Jenssen, Christian Șirli, Roxana Popescu, Alina Lim, Adrian |
AuthorAffiliation | 7 Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China; drdaisydong@hotmail.com 1 Department of Gastroenterology and Hepatology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; roxanasirli@gmail.com (R.Ș.); alinamircea.popescu@gmail.com (A.P.); isporea@umft.ro (I.S.) 6 Department of Imaging, Imperial College London and Healthcare NHS Trust, London W6 8RF, UK; a.lim@imperial.ac.uk 8 Faculty of Medicine and Philosophy and Faculty of Health Sciences Brandenburg, 16816 Neuruppin, Germany; nuernbergdieter@gmx.de 4 Brandenburg Institute for Clinical Ultrasound (BICUS) at Medical University Brandenburg “Theodor Fontane”, 16816 Neuruppin, Germany 3 Department of Internal Medicine, Krankenhaus Märkisch Oderland GmbH, 15344 Strausberg, Germany; c.jenssen@khmol.de 2 Center for Advanced Research in Gastroenterology and Hepatology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara |
AuthorAffiliation_xml | – name: 8 Faculty of Medicine and Philosophy and Faculty of Health Sciences Brandenburg, 16816 Neuruppin, Germany; nuernbergdieter@gmx.de – name: 7 Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China; drdaisydong@hotmail.com – name: 5 Medical Department I/Gastroenterology, SANA Hospital Lichtenberg, 10365 Berlin, Germany; k.moeller@live.de – name: 6 Department of Imaging, Imperial College London and Healthcare NHS Trust, London W6 8RF, UK; a.lim@imperial.ac.uk – name: 3 Department of Internal Medicine, Krankenhaus Märkisch Oderland GmbH, 15344 Strausberg, Germany; c.jenssen@khmol.de – name: 9 Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Salem und Permanence, 3013 Bern, Switzerland; marieke.petry@gmx.de – name: 4 Brandenburg Institute for Clinical Ultrasound (BICUS) at Medical University Brandenburg “Theodor Fontane”, 16816 Neuruppin, Germany – name: 2 Center for Advanced Research in Gastroenterology and Hepatology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania – name: 1 Department of Gastroenterology and Hepatology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; roxanasirli@gmail.com (R.Ș.); alinamircea.popescu@gmail.com (A.P.); isporea@umft.ro (I.S.) |
Author_xml | – sequence: 1 givenname: Roxana orcidid: 0000-0002-0179-1014 surname: Șirli fullname: Șirli, Roxana – sequence: 2 givenname: Alina orcidid: 0000-0002-9141-7228 surname: Popescu fullname: Popescu, Alina – sequence: 3 givenname: Christian orcidid: 0000-0002-7008-6650 surname: Jenssen fullname: Jenssen, Christian – sequence: 4 givenname: Kathleen orcidid: 0009-0002-9492-0141 surname: Möller fullname: Möller, Kathleen – sequence: 5 givenname: Adrian surname: Lim fullname: Lim, Adrian – sequence: 6 givenname: Yi surname: Dong fullname: Dong, Yi – sequence: 7 givenname: Ioan surname: Sporea fullname: Sporea, Ioan – sequence: 8 givenname: Dieter surname: Nürnberg fullname: Nürnberg, Dieter – sequence: 9 givenname: Marieke surname: Petry fullname: Petry, Marieke – sequence: 10 givenname: Christoph F. orcidid: 0000-0001-6015-6347 surname: Dietrich fullname: Dietrich, Christoph F. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39199678$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ksFv2yAUxtHUae26nnebkHbpYUnB2GB2mdpqWSqlatWt2mEHhPFzQuRABnai_vfDajul0QYHEPy-7_Hp8RYdOO8AofeUjBmT5MxoZyBEyinPJClfoaOMiGzEucwPdvaH6CTGJUmDMSq4eIMOmaRSclEeoV8_J_fXF_gONha2-FavIYzxlTO2BtfpFk-sq62bR2wdvukWELY2Ap6CbrvFA_7eV0swXfyEp36LO4-vtdNz-IxndgPhHXrd6DbCydN6jO4nX39cTkezm29Xl-ezkclL2Y00FKKpKskyI6AxAIVs6oKylEpIVkBdspSCSWHqPBGMFFpXvKw5zY3UgrJj9OXRd91XK6hNennQrVoHu9LhQXlt1csbZxdq7jeKUlZkQpTJ4fTJIfjfPcROrWw00Lbage-jYkRKmtOCFwn9uIcufR9cyjdQyYuUYoea6xaUdY1Phc1gqs5LIvIsz8lQdvwPKs0aVtakZjc2nb8QfNhN-jficz8TUDwCJvgYAzTK2E531g_BbasoUcPXUXtfJ-nO9nTP1v9T_AGMGsUY |
CitedBy_id | crossref_primary_10_1080_17474124_2024_2444554 crossref_primary_10_3390_diagnostics15010046 |
Cites_doi | 10.1002/jum.15644 10.1136/gut.2010.222109 10.1016/j.jhep.2016.04.001 10.1016/j.ultrasmedbio.2014.11.012 10.1016/S0168-8278(86)80012-5 10.1148/radiology.210.1.r99ja0371 10.1159/000507923 10.1111/j.1477-2574.2010.00222.x 10.1136/bcr-2013-200539 10.2214/AJR.13.12251 10.1016/j.diii.2015.05.012 10.12998/wjcc.v7.i7.809 10.3390/cancers15082360 10.1055/a-0650-3807 10.3233/CH-200896 10.2214/ajr.158.3.1738990 10.1016/j.crad.2022.05.032 10.2214/AJR.11.7046 10.11152/mu-4091 10.1055/s-0029-1245565 10.1002/hep.21615 10.1007/s00330-018-5784-5 10.14366/usg.16041 10.1111/j.1365-2303.2011.00882.x 10.3748/wjg.15.3748 10.3350/cmh.2017.0037 10.1055/s-0042-124369 10.2214/AJR.20.22768 10.1055/s-0028-1109673 10.1007/s00330-017-5152-x 10.11152/mu-1349 10.1016/j.gassur.2004.06.001 10.1016/j.cgh.2020.12.016 10.1148/radiol.2481071451 10.14218/JCTH.2019.00017 10.11152/mu-4065 10.1053/j.sult.2009.09.004 10.5009/gnl14324 10.2147/HMER.S284842 10.11152/mu-940 10.4254/wjh.v7.i16.1987 10.1055/s-0034-1399282 10.1055/s-2007-963785 10.1016/j.ultrasmedbio.2021.03.032 10.1016/j.jhep.2014.04.044 10.1055/s-2004-812712 10.21037/qims-22-1035 10.1055/s-2004-813245 10.1245/s10434-008-0275-6 10.1007/s00436-016-5116-0 10.11152/mu-925 10.1007/s00330-022-08988-w 10.2214/AJR.19.21251 10.1155/1991/96304 10.7863/ultra.32.9.1557 10.1055/s-0035-1554036 10.1016/j.ultrasmedbio.2020.04.030 10.1016/j.acra.2021.08.025 10.1016/j.ultrasmedbio.2021.09.015 10.1007/s00261-022-03436-1 10.1002/hep.21966 10.1055/s-2008-1027555 10.1148/radiol.2373041364 10.1016/j.clinre.2023.102094 10.1016/j.ultrasmedbio.2018.07.008 10.1007/s00384-002-0397-4 10.11152/mu-4260 10.1007/s00261-015-0605-7 10.1055/s-0029-1245649 10.1159/000367726 10.1590/S0100-39842013000400005 10.1007/s00330-010-1757-z 10.1259/bjr.20210220 10.1007/s00432-011-1035-8 10.2214/AJR.08.2294 10.1056/NEJMra072149 10.1080/028418501127346468 10.1002/hep.29086 10.1016/j.ultrasmedbio.2021.05.022 10.1097/SLA.0000000000005108 10.1016/j.ejrad.2008.08.011 10.14366/usg.19029 10.1055/s-0043-103952 10.11152/mu-4261 10.1016/j.ejrad.2017.08.018 10.1016/j.ultrasmedbio.2012.09.002 10.1136/bmjopen-2021-056572 10.1007/s00330-019-06331-4 10.1007/s00261-015-0567-9 10.1016/j.dld.2011.11.007 10.1371/journal.pone.0129720 10.1136/gut.2003.032359 10.1002/jmri.21147 10.1055/s-2008-1027806 10.1002/jmri.22833 10.1016/j.jhep.2017.11.007 10.2214/ajr.159.5.1329454 10.1016/j.ultrasmedbio.2021.09.010 10.1053/j.gastro.2016.11.042 10.1016/j.jacr.2019.12.024 10.1016/j.ultrasmedbio.2011.03.006 10.1016/j.ultrasmedbio.2023.03.026 10.1148/radiol.212317 10.1016/j.suc.2010.04.005 10.1016/j.ultrasmedbio.2018.06.015 10.1016/j.cgh.2013.09.017 10.1016/j.jacr.2017.07.018 10.1016/j.ultsonch.2023.106716 10.1136/gutjnl-2020-321299 10.1055/s-0031-1299276 10.3350/cmh.2019.0010 10.3109/00365521.2014.999349 10.1016/j.jacr.2016.09.044 10.1007/s11605-020-04724-1 10.3748/wjg.v11.i40.6354 10.1016/j.ultrasmedbio.2022.06.016 10.1007/s00330-020-06726-8 10.1055/s-0029-1245383 10.1007/s00330-019-06566-1 10.1136/bmjgast-2020-000592 10.1111/liv.14547 10.1080/003655202760373399 10.1038/ajg.2014.213 10.1007/s10654-020-00679-4 10.11152/mu-4192 10.1111/liv.12115 10.1007/s00117-017-0235-x 10.1016/j.ejrad.2020.109027 10.1016/j.ultrasmedbio.2020.02.002 10.1590/s0004-28032015000500003 10.1016/j.ultrasmedbio.2017.05.011 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2024 MDPI AG 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 by the authors. 2024 |
Copyright_xml | – notice: COPYRIGHT 2024 MDPI AG – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 by the authors. 2024 |
DBID | AAYXX CITATION NPM 3V. 7T5 7TO 7XB 8FE 8FH 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ GUQSH H94 HCIFZ LK8 M2O M7P MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.3390/cancers16162908 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Immunology Abstracts Oncogenes and Growth Factors Abstracts ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection Biological Sciences Research Library Biological Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2072-6694 |
ExternalDocumentID | PMC11352778 A807424408 39199678 10_3390_cancers16162908 |
Genre | Journal Article Review |
GeographicLocations | Romania |
GeographicLocations_xml | – name: Romania |
GroupedDBID | --- 53G 5VS 8FE 8FH 8G5 AADQD AAFWJ AAYXX ABDBF ABUWG ACUHS ADBBV AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION DIK DWQXO E3Z EBD ESX GNUQQ GUQSH GX1 HCIFZ HYE IAO IHR ITC KQ8 LK8 M2O M48 M7P MODMG M~E OK1 P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RPM TUS NPM PQGLB PMFND 3V. 7T5 7TO 7XB 8FK H94 MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c489t-ae57fbb932c7efcee59fd5131627935ed83694397cd4c7e305aab68d614c9a713 |
IEDL.DBID | M48 |
ISSN | 2072-6694 |
IngestDate | Thu Aug 21 18:31:54 EDT 2025 Fri Sep 05 04:08:00 EDT 2025 Fri Jul 25 11:41:40 EDT 2025 Tue Jun 17 22:04:24 EDT 2025 Tue Jun 10 21:03:11 EDT 2025 Mon Jul 21 05:54:40 EDT 2025 Thu Apr 24 23:00:55 EDT 2025 Tue Jul 01 01:08:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16 |
Keywords | asymptomatic patients contrast enhanced ultrasound (CEUS) incidental focal liver lesion ultrasound |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c489t-ae57fbb932c7efcee59fd5131627935ed83694397cd4c7e305aab68d614c9a713 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0009-0002-9492-0141 0000-0002-0179-1014 0000-0001-6015-6347 0000-0002-7008-6650 0000-0002-9141-7228 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/cancers16162908 |
PMID | 39199678 |
PQID | 3097830875 |
PQPubID | 2032421 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11352778 proquest_miscellaneous_3099141565 proquest_journals_3097830875 gale_infotracmisc_A807424408 gale_infotracacademiconefile_A807424408 pubmed_primary_39199678 crossref_citationtrail_10_3390_cancers16162908 crossref_primary_10_3390_cancers16162908 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20240821 |
PublicationDateYYYYMMDD | 2024-08-21 |
PublicationDate_xml | – month: 8 year: 2024 text: 20240821 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Cancers |
PublicationTitleAlternate | Cancers (Basel) |
PublicationYear | 2024 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Julien (ref_132) 2021; 274 Taimr (ref_114) 2017; 43 Nguyen (ref_29) 2017; 14 Volk (ref_28) 2001; 42 Gore (ref_11) 2017; 14 Dietrich (ref_99) 2019; 45 Ignee (ref_117) 2023; 25 Schmidt (ref_37) 2022; 12 Bernatik (ref_75) 2010; 31 Dietrich (ref_1) 2020; 46 Jenssen (ref_7) 2022; 48 Haring (ref_98) 2023; 47 Bartolotta (ref_120) 2017; 36 Gronlykke (ref_138) 2013; 2013 Dietrich (ref_133) 2018; 56 Huang (ref_81) 2022; 32 Hardie (ref_105) 2022; 29 Deneve (ref_126) 2009; 16 Farges (ref_92) 2011; 60 Haring (ref_97) 2021; 8 Collin (ref_35) 2015; 50 Bialek (ref_3) 2021; 23 Yoon (ref_80) 2010; 20 Schwartz (ref_66) 1999; 210 Dietrich (ref_6) 2022; 48 Moller (ref_118) 2023; 25 Kudo (ref_127) 2015; 4 Claudon (ref_43) 2013; 39 Tsapaki (ref_65) 2010; 31 McIntyre (ref_107) 2022; 47 Wee (ref_77) 2011; 22 Knox (ref_31) 2017; 95 Wernecke (ref_102) 1992; 159 Frydrychowicz (ref_68) 2012; 35 Herman (ref_101) 2021; 25 Laumonier (ref_93) 2012; 199 Stoot (ref_91) 2010; 12 Cassinotto (ref_52) 2014; 61 Little (ref_26) 1991; 4 Petousis (ref_9) 2022; 48 Dietrich (ref_2) 2020; 39 Wilson (ref_87) 2022; 77 Averbukh (ref_103) 2019; 7 Boyum (ref_104) 2021; 216 Wang (ref_94) 2012; 44 DiPiro (ref_30) 2020; 17 Wu (ref_42) 2018; 28 Sporea (ref_44) 2017; 19 Zander (ref_119) 2023; 25 Xie (ref_47) 2011; 37 Dewey (ref_70) 2007; 26 Tana (ref_140) 2019; 7 Burrowes (ref_49) 2021; 40 Ren (ref_25) 2019; 39 Broker (ref_129) 2020; 214 Strobel (ref_84) 2015; 36 Zheng (ref_109) 2005; 11 Mettler (ref_64) 2008; 248 Venkatesh (ref_34) 2014; 12 Trenker (ref_5) 2021; 47 Caturelli (ref_76) 2004; 53 Claudon (ref_90) 2008; 29 Jang (ref_16) 2009; 72 Dietrich (ref_39) 2020; 46 Hirche (ref_23) 2002; 37 Marrero (ref_74) 2014; 109 Neuberger (ref_73) 2020; 69 Boutros (ref_21) 2010; 90 Dietrich (ref_50) 2017; 38 Strauss (ref_123) 2015; 52 ref_58 Dong (ref_111) 2023; 49 Yang (ref_17) 2019; 25 Kaltenbach (ref_22) 2016; 41 Guang (ref_46) 2011; 137 Dorffel (ref_122) 2008; 29 Imajo (ref_54) 2022; 20 Matos (ref_67) 2015; 7 Dong (ref_116) 2023; 26 Pech (ref_108) 2016; 97 Auer (ref_125) 2020; 30 Schlottmann (ref_79) 2004; 42 Choi (ref_24) 2016; 41 Park (ref_61) 2013; 32 Lewicki (ref_4) 2021; 47 Heide (ref_56) 2010; 31 Klompenhouwer (ref_131) 2020; 40 Kong (ref_113) 2015; 41 Chen (ref_59) 2023; 101 Dietrich (ref_85) 2016; 37 Agarwal (ref_112) 2014; 203 Dong (ref_137) 2020; 102 Strobel (ref_86) 2003; 18 ref_69 Kim (ref_134) 2017; 23 Xu (ref_95) 2012; 33 Brunetti (ref_141) 2018; 4 Brenner (ref_62) 2007; 357 Kono (ref_135) 2017; 38 Galvao (ref_32) 2013; 46 Bise (ref_124) 2019; 29 Seitz (ref_128) 2009; 30 Richter (ref_36) 2020; 35 Terzi (ref_38) 2018; 68 Kong (ref_121) 2016; 10 Jiao (ref_55) 2017; 19 Gregory (ref_130) 2020; 128 Cannella (ref_57) 2021; 94 Wu (ref_82) 2022; 305 Klopffleisch (ref_41) 2013; 33 Linhart (ref_13) 1998; 123 Sidhu (ref_71) 2015; 36 Devine (ref_27) 2010; 11 Ferraioli (ref_51) 2018; 44 Lefebvre (ref_53) 2019; 29 Lorentzen (ref_83) 2015; 36 Trillaud (ref_48) 2009; 15 Fu (ref_136) 2021; 77 Scharitzer (ref_10) 2017; 57 Richter (ref_142) 2016; 115 Frulio (ref_115) 2020; 30 Okamoto (ref_60) 2010; 194 Nault (ref_96) 2017; 152 (ref_63) 2012; 172 Loizides (ref_139) 2017; 19 Lu (ref_12) 1990; 6 Holland (ref_15) 2005; 237 Albrecht (ref_89) 2004; 25 Tang (ref_45) 2023; 13 Rungsinaporn (ref_14) 2008; 91 Dong (ref_88) 2024; 26 ref_100 Hutchens (ref_106) 2023; 15 Liu (ref_33) 2004; 8 Strobel (ref_40) 2008; 29 Dietrich (ref_110) 2007; 45 Forner (ref_78) 2008; 47 ref_8 Laghi (ref_19) 2010; 31 Jones (ref_18) 1992; 158 Karhunen (ref_20) 1986; 2 Heimbach (ref_72) 2018; 67 |
References_xml | – volume: 40 start-page: 2581 year: 2021 ident: ref_49 article-title: Characterization of Focal Liver Masses: A Multicenter Comparison of Contrast-Enhanced Ultrasound, Computed Tomography, and Magnetic Resonance Imaging publication-title: J. Ultrasound Med. doi: 10.1002/jum.15644 – volume: 60 start-page: 85 year: 2011 ident: ref_92 article-title: Changing trends in malignant transformation of hepatocellular adenoma publication-title: Gut doi: 10.1136/gut.2010.222109 – volume: 23 start-page: 329 year: 2021 ident: ref_3 article-title: WFUMB position paper publication-title: Incidental Find. Salivary Glands. Med. Ultrason. – ident: ref_58 doi: 10.1016/j.jhep.2016.04.001 – volume: 91 start-page: 1072 year: 2008 ident: ref_14 article-title: Frequency of abnormalities detected by upper abdominal ultrasound publication-title: J. Med. Assoc. Thai. – volume: 41 start-page: 944 year: 2015 ident: ref_113 article-title: Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2014.11.012 – ident: ref_100 – volume: 2 start-page: 89 year: 1986 ident: ref_20 article-title: Benign bile duct tumours, non-parasitic liver cysts and liver damage in males publication-title: J. Hepatol. doi: 10.1016/S0168-8278(86)80012-5 – volume: 210 start-page: 71 year: 1999 ident: ref_66 article-title: Prevalence and importance of small hepatic lesions found at CT in patients with cancer publication-title: Radiology doi: 10.1148/radiology.210.1.r99ja0371 – volume: 102 start-page: 335 year: 2020 ident: ref_137 article-title: Current Opinion about Hepatocellular Carcinoma < 10 mm publication-title: Digestion doi: 10.1159/000507923 – volume: 12 start-page: 509 year: 2010 ident: ref_91 article-title: Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: A systematic review including more than 1600 adenoma cases publication-title: HPB doi: 10.1111/j.1477-2574.2010.00222.x – volume: 2013 start-page: bcr2013200539 year: 2013 ident: ref_138 article-title: Peliosis hepatis: A complicating finding in a case of biliary colic publication-title: BMJ Case Rep. doi: 10.1136/bcr-2013-200539 – volume: 203 start-page: W408 year: 2014 ident: ref_112 article-title: Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI publication-title: AJR Am. J. Roentgenol. doi: 10.2214/AJR.13.12251 – volume: 97 start-page: 401 year: 2016 ident: ref_108 article-title: Imaging of Von Meyenburg complexes publication-title: Diagn. Interv. Imaging doi: 10.1016/j.diii.2015.05.012 – volume: 7 start-page: 809 year: 2019 ident: ref_140 article-title: Ultrasound imaging of abdominal sarcoidosis: State of the art publication-title: World J. Clin. Cases doi: 10.12998/wjcc.v7.i7.809 – ident: ref_8 doi: 10.3390/cancers15082360 – volume: 4 start-page: E70 year: 2018 ident: ref_141 article-title: Ultrasound and Cystic Echinococcosis publication-title: Ultrasound Int. Open doi: 10.1055/a-0650-3807 – volume: 77 start-page: 49 year: 2021 ident: ref_136 article-title: Imaging findings of fibrolamellar hepatocellular carcinomas on ultrasonography: A comparison with conventional hepatocellular carcinomas publication-title: Clin. Hemorheol. Microcirc. doi: 10.3233/CH-200896 – volume: 158 start-page: 535 year: 1992 ident: ref_18 article-title: The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT publication-title: AJR Am. J. Roentgenol. doi: 10.2214/ajr.158.3.1738990 – volume: 77 start-page: e807 year: 2022 ident: ref_87 article-title: Microvascular imaging: New Doppler technology for assessing focal liver lesions. Is it useful? publication-title: Clin. Radiol. doi: 10.1016/j.crad.2022.05.032 – volume: 199 start-page: 341 year: 2012 ident: ref_93 article-title: Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: Correlation with MRI findings publication-title: AJR Am. J. Roentgenol. doi: 10.2214/AJR.11.7046 – volume: 25 start-page: 423 year: 2023 ident: ref_119 article-title: Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesion—Infectious parasitic, fungus publication-title: Med. Ultrason. doi: 10.11152/mu-4091 – volume: 31 start-page: 405 year: 2010 ident: ref_56 article-title: Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry publication-title: Ultraschall Med. doi: 10.1055/s-0029-1245565 – volume: 45 start-page: 1139 year: 2007 ident: ref_110 article-title: Contrast-enhanced ultrasound of histologically proven liver hemangiomas publication-title: Hepatology doi: 10.1002/hep.21615 – volume: 29 start-page: 2436 year: 2019 ident: ref_124 article-title: New MRI features improve subtype classification of hepatocellular adenoma publication-title: Eur. Radiol. doi: 10.1007/s00330-018-5784-5 – volume: 36 start-page: 160 year: 2017 ident: ref_120 article-title: Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver: The added value of contrast-enhanced sonography publication-title: Ultrasonography doi: 10.14366/usg.16041 – volume: 22 start-page: 287 year: 2011 ident: ref_77 article-title: Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: Role, controversies and approach to diagnosis publication-title: Cytopathology doi: 10.1111/j.1365-2303.2011.00882.x – volume: 15 start-page: 3748 year: 2009 ident: ref_48 article-title: Characterization of focal liver lesions with SonoVue-enhanced sonography: International multicenter-study in comparison to CT and MRI publication-title: World J. Gastroenterol. doi: 10.3748/wjg.15.3748 – volume: 23 start-page: 280 year: 2017 ident: ref_134 article-title: Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017—A review of important differences compared to the CT/MRI system publication-title: Clin. Mol. Hepatol. doi: 10.3350/cmh.2017.0037 – volume: 38 start-page: 85 year: 2017 ident: ref_135 article-title: Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS(R)): The official version by the American College of Radiology (ACR) publication-title: Ultraschall Med. doi: 10.1055/s-0042-124369 – volume: 216 start-page: 403 year: 2021 ident: ref_104 article-title: Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI publication-title: AJR Am. J. Roentgenol. doi: 10.2214/AJR.20.22768 – volume: 30 start-page: 383 year: 2009 ident: ref_128 article-title: Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions—Prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos publication-title: Ultraschall Med. doi: 10.1055/s-0028-1109673 – volume: 28 start-page: 2077 year: 2018 ident: ref_42 article-title: Contrast-enhanced US for characterization of focal liver lesions: A comprehensive meta-analysis publication-title: Eur. Radiol. doi: 10.1007/s00330-017-5152-x – volume: 19 start-page: 401 year: 2017 ident: ref_44 article-title: Romanian National Guidelines on Contrast Enhanced Ultrasound in clinical practice publication-title: Med. Ultrason. doi: 10.11152/mu-1349 – volume: 8 start-page: 785 year: 2004 ident: ref_33 article-title: Hepatic resection for incidentaloma publication-title: J. Gastrointest. Surg. doi: 10.1016/j.gassur.2004.06.001 – volume: 20 start-page: 908 year: 2022 ident: ref_54 article-title: Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2020.12.016 – volume: 248 start-page: 254 year: 2008 ident: ref_64 article-title: Effective doses in radiology and diagnostic nuclear medicine: A catalog publication-title: Radiology doi: 10.1148/radiol.2481071451 – volume: 37 start-page: E1 year: 2016 ident: ref_85 article-title: EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III—Abdominal Treatment Procedures (Long Version) publication-title: Ultraschall Med. – volume: 7 start-page: 149 year: 2019 ident: ref_103 article-title: Biliary Mucinous Cystadenoma: A Review of the Literature publication-title: J. Clin. Transl. Hepatol. doi: 10.14218/JCTH.2019.00017 – volume: 25 start-page: 312 year: 2023 ident: ref_117 article-title: Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesions—Infectious (bacterial) publication-title: Med. Ultrason. doi: 10.11152/mu-4065 – volume: 31 start-page: 29 year: 2010 ident: ref_65 article-title: Radiation safety in abdominal computed tomography publication-title: Semin. Ultrasound CT MR doi: 10.1053/j.sult.2009.09.004 – volume: 11 start-page: 24 year: 2010 ident: ref_27 article-title: Frequency of incidental findings on computed tomography of trauma patients publication-title: West J. Emerg. Med. – volume: 10 start-page: 283 year: 2016 ident: ref_121 article-title: Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors publication-title: Gut Liver doi: 10.5009/gnl14324 – volume: 15 start-page: 33 year: 2023 ident: ref_106 article-title: Mucinous Cystic Neoplasms of the Liver: Epidemiology, Diagnosis, and Management publication-title: Hepat. Med. doi: 10.2147/HMER.S284842 – volume: 19 start-page: 114 year: 2017 ident: ref_139 article-title: Contrast enhanced ultrasound of a rare case of Peliosis hepatis publication-title: Med. Ultrason. doi: 10.11152/mu-940 – volume: 7 start-page: 1987 year: 2015 ident: ref_67 article-title: Focal liver lesions: Practical magnetic resonance imaging approach publication-title: World J. Hepatol. doi: 10.4254/wjh.v7.i16.1987 – volume: 36 start-page: 122 year: 2015 ident: ref_84 article-title: Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions—Results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study) publication-title: Ultraschall Med. doi: 10.1055/s-0034-1399282 – volume: 29 start-page: 28 year: 2008 ident: ref_90 article-title: Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—Update 2008 publication-title: Ultraschall Med. doi: 10.1055/s-2007-963785 – volume: 47 start-page: 2017 year: 2021 ident: ref_5 article-title: WFUMB Position Paper-Incidental Findings, How to Manage: Spleen publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2021.03.032 – volume: 61 start-page: 550 year: 2014 ident: ref_52 article-title: Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan(R) publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.04.044 – volume: 36 start-page: E1 year: 2015 ident: ref_83 article-title: EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I. General Aspects (long Version) publication-title: Ultraschall Med. – volume: 42 start-page: 303 year: 2004 ident: ref_79 article-title: Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode publication-title: Z. Gastroenterol. doi: 10.1055/s-2004-812712 – volume: 13 start-page: 3150 year: 2023 ident: ref_45 article-title: Prolonged heterogeneous liver enhancement accompanied by abdominal symptoms after sonographic contrast agent injection: A cross-sectional study publication-title: Quant. Imaging Med. Surg. doi: 10.21037/qims-22-1035 – volume: 25 start-page: 249 year: 2004 ident: ref_89 article-title: Guidelines for the use of contrast agents in ultrasound. January 2004 publication-title: Ultraschall Med. doi: 10.1055/s-2004-813245 – volume: 16 start-page: 640 year: 2009 ident: ref_126 article-title: Liver cell adenoma: A multicenter analysis of risk factors for rupture and malignancy publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-008-0275-6 – volume: 56 start-page: 499 year: 2018 ident: ref_133 article-title: Contrast-enhanced ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS) publication-title: Z Gastroenterol. – volume: 115 start-page: 2917 year: 2016 ident: ref_142 article-title: Ultrasonography of gallbladder abnormalities due to schistosomiasis publication-title: Parasitol. Res. doi: 10.1007/s00436-016-5116-0 – volume: 19 start-page: 16 year: 2017 ident: ref_55 article-title: Shear wave elastography imaging for detecting malignant lesions of the liver: A systematic review and pooled meta-analysis publication-title: Med. Ultrason. doi: 10.11152/mu-925 – volume: 32 start-page: 6830 year: 2022 ident: ref_81 article-title: The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: A retrospective study of 820 cases publication-title: Eur. Radiol. doi: 10.1007/s00330-022-08988-w – volume: 214 start-page: 81 year: 2020 ident: ref_129 article-title: Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia publication-title: AJR Am. J. Roentgenol. doi: 10.2214/AJR.19.21251 – volume: 4 start-page: 291 year: 1991 ident: ref_26 article-title: Hepatic dystychoma: A five year experience publication-title: HPB Surg. doi: 10.1155/1991/96304 – volume: 32 start-page: 1557 year: 2013 ident: ref_61 article-title: Fusion imaging-guided percutaneous biopsy of focal hepatic lesions with poor conspicuity on conventional sonography publication-title: J. Ultrasound Med. doi: 10.7863/ultra.32.9.1557 – volume: 36 start-page: E15 year: 2015 ident: ref_71 article-title: EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II. Diagnostic Ultrasound-Guided Interventional Procedures (Long Version) publication-title: Ultraschall Med. doi: 10.1055/s-0035-1554036 – volume: 46 start-page: 2579 year: 2020 ident: ref_39 article-title: Guidelines Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with, EFSUMB, AFSUMB, AIUM and FLAUS publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2020.04.030 – volume: 29 start-page: 1149 year: 2022 ident: ref_105 article-title: Multi-Center Follow-up Study to Develop a Classification System Which Differentiates Mucinous Cystic Neoplasm of the Liver and Benign Hepatic Cyst Using Machine Learning publication-title: Acad. Radiol. doi: 10.1016/j.acra.2021.08.025 – volume: 48 start-page: 180 year: 2022 ident: ref_6 article-title: Managing Incidental Findings Reported by Medical, Sonography and Other Students Performing Educational Ultrasound Examinations publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2021.09.015 – volume: 47 start-page: 1333 year: 2022 ident: ref_107 article-title: Differentiation of mucinous cysts and simple cysts of the liver using preoperative imaging publication-title: Abdom. Radiol. doi: 10.1007/s00261-022-03436-1 – volume: 47 start-page: 97 year: 2008 ident: ref_78 article-title: Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.21966 – volume: 29 start-page: 506 year: 2008 ident: ref_122 article-title: Neuroendocrine tumors: Characterization with contrast-enhanced ultrasonography publication-title: Ultraschall Med. doi: 10.1055/s-2008-1027555 – volume: 237 start-page: 938 year: 2005 ident: ref_15 article-title: Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: Evaluation and comparison with whole explanted liver publication-title: Radiology doi: 10.1148/radiol.2373041364 – volume: 47 start-page: 102094 year: 2023 ident: ref_98 article-title: Variation in the management of benign liver tumors: A European survey and case vignette study publication-title: Clin. Res. Hepatol. Gastroenterol. doi: 10.1016/j.clinre.2023.102094 – volume: 44 start-page: 2419 year: 2018 ident: ref_51 article-title: Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2018.07.008 – volume: 18 start-page: 63 year: 2003 ident: ref_86 article-title: Phase inversion harmonic imaging versus contrast-enhanced power Doppler sonography for the characterization of focal liver lesions publication-title: Int. J. Colorectal. Dis. doi: 10.1007/s00384-002-0397-4 – volume: 26 start-page: 50 year: 2024 ident: ref_88 article-title: Comments illustrations of the WFUMBCEUS liver guidelines: Rare benign focal liver lesion part I publication-title: Med. Ultrason. doi: 10.11152/mu-4260 – volume: 41 start-page: 25 year: 2016 ident: ref_22 article-title: Prevalence of benign focal liver lesions: Ultrasound investigation of 45,319 hospital patients publication-title: Abdom. Radiol. doi: 10.1007/s00261-015-0605-7 – volume: 31 start-page: 577 year: 2010 ident: ref_75 article-title: Unclear focal liver lesions in contrast-enhanced ultrasonography—Lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors publication-title: Ultraschall Med. doi: 10.1055/s-0029-1245649 – volume: 4 start-page: 1 year: 2015 ident: ref_127 article-title: Malignant transformation of hepatocellular adenoma: How frequently does it happen? publication-title: Liver Cancer doi: 10.1159/000367726 – volume: 46 start-page: 203 year: 2013 ident: ref_32 article-title: Prevalence of simple liver cysts and hemangiomas in cirrhotic and non-cirrhotic patients submitted to magnetic resonance imaging publication-title: J. Radiol. Bras. doi: 10.1590/S0100-39842013000400005 – volume: 20 start-page: 2047 year: 2010 ident: ref_80 article-title: Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound publication-title: Eur. Radiol. doi: 10.1007/s00330-010-1757-z – volume: 94 start-page: 20210220 year: 2021 ident: ref_57 article-title: Quantitative magnetic resonance imaging for focal liver lesions: Bridging the gap between research and clinical practice publication-title: Br. J. Radiol. doi: 10.1259/bjr.20210220 – volume: 137 start-page: 1595 year: 2011 ident: ref_46 article-title: Diagnosis value of focal liver lesions with SonoVue(R)-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: A meta-analysis publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-011-1035-8 – volume: 194 start-page: 1272 year: 2010 ident: ref_60 article-title: Evaluation of virtual CT sonography for enhanced detection of small hepatic nodules: A prospective pilot study publication-title: AJR Am. J. Roentgenol. doi: 10.2214/AJR.08.2294 – volume: 357 start-page: 2277 year: 2007 ident: ref_62 article-title: Computed tomography—An increasing source of radiation exposure publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra072149 – volume: 42 start-page: 172 year: 2001 ident: ref_28 article-title: Frequency of benign hepatic lesions incidentally detected with contrast-enhanced thin-section portal venous phase spiral CT publication-title: Acta Radiol. doi: 10.1080/028418501127346468 – volume: 67 start-page: 358 year: 2018 ident: ref_72 article-title: AASLD guidelines for the treatment of hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.29086 – volume: 47 start-page: 2787 year: 2021 ident: ref_4 article-title: Incidental Findings and How to Manage Them: Testis—A WFUMB Position Paper publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2021.05.022 – volume: 274 start-page: 843 year: 2021 ident: ref_132 article-title: Hepatocellular Adenoma Risk Factors of Hemorrhage: Size is not the only Concern! Single Center Retrospective Experience of 261 Patients publication-title: Ann. Surg. doi: 10.1097/SLA.0000000000005108 – volume: 72 start-page: 418 year: 2009 ident: ref_16 article-title: Small nodules (1–2 cm) in liver cirrhosis: Characterization with contrast-enhanced ultrasound publication-title: Eur. J. Radiol. doi: 10.1016/j.ejrad.2008.08.011 – volume: 39 start-page: 11 year: 2020 ident: ref_2 article-title: WFUMB position paper on the management incidental findings: Adrenal incidentaloma publication-title: Ultrasonography doi: 10.14366/usg.19029 – volume: 38 start-page: e16 year: 2017 ident: ref_50 article-title: EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) publication-title: Ultraschall Med. doi: 10.1055/s-0043-103952 – volume: 26 start-page: 168 year: 2023 ident: ref_116 article-title: Comments illustrations of the WFUMBCEUS liver guidelines: Rare benign focal liver lesion part II publication-title: Med. Ultrason. doi: 10.11152/mu-4261 – volume: 95 start-page: 319 year: 2017 ident: ref_31 article-title: Incidental liver lesions seen on Breast MRI: When is additional imaging warranted? publication-title: Eur. J. Radiol. doi: 10.1016/j.ejrad.2017.08.018 – volume: 39 start-page: 187 year: 2013 ident: ref_43 article-title: Guidelines good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver—Update 2012: AWFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2012.09.002 – volume: 12 start-page: e056572 year: 2022 ident: ref_37 article-title: Effects of whole-body MRI on outpatient health service costs: A general-population prospective cohort study in Mecklenburg-Vorpommern, Germany publication-title: BMJ Open doi: 10.1136/bmjopen-2021-056572 – volume: 29 start-page: 6477 year: 2019 ident: ref_53 article-title: Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis publication-title: Eur. Radiol. doi: 10.1007/s00330-019-06331-4 – volume: 41 start-page: 265 year: 2016 ident: ref_24 article-title: Focal hepatic solid lesions incidentally detected on initial ultrasonography in 542 asymptomatic patients publication-title: Abdom. Radiol. doi: 10.1007/s00261-015-0567-9 – volume: 172 start-page: 1023 year: 2012 ident: ref_63 article-title: Environmental causes of breast cancer and radiation from medical imaging: Findings from the Institute of Medicine report publication-title: Arch. Intern. Med. – volume: 44 start-page: 426 year: 2012 ident: ref_94 article-title: Intrahepatic biliary cystadenoma and cystadenocarcinoma: An experience of 30 cases publication-title: Dig. Liver Dis. doi: 10.1016/j.dld.2011.11.007 – ident: ref_69 doi: 10.1371/journal.pone.0129720 – volume: 53 start-page: 1356 year: 2004 ident: ref_76 article-title: Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: A multicentre study publication-title: Gut doi: 10.1136/gut.2003.032359 – volume: 26 start-page: 1322 year: 2007 ident: ref_70 article-title: Claustrophobia during magnetic resonance imaging: Cohort study in over 55,000 patients publication-title: J. Magn. Reson. Imaging. doi: 10.1002/jmri.21147 – volume: 29 start-page: 499 year: 2008 ident: ref_40 article-title: Contrast-enhanced ultrasound for the characterization of focal liver lesions—Diagnostic accuracy in clinical practice (DEGUM multicenter trial) publication-title: Ultraschall Med. doi: 10.1055/s-2008-1027806 – volume: 35 start-page: 492 year: 2012 ident: ref_68 article-title: Hepatobiliary MR imaging with gadolinium-based contrast agents publication-title: J. Magn. Reson. Imaging doi: 10.1002/jmri.22833 – volume: 68 start-page: 485 year: 2018 ident: ref_38 article-title: Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1006 nodules publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.11.007 – volume: 159 start-page: 1005 year: 1992 ident: ref_102 article-title: The distinction between benign and malignant liver tumors on sonography: Value of a hypoechoic halo publication-title: AJR Am. J. Roentgenol. doi: 10.2214/ajr.159.5.1329454 – volume: 48 start-page: 10 year: 2022 ident: ref_9 article-title: World Federation for Ultrasound in Medicine Review Paper: Incidental Findings during Obstetrical Ultrasound publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2021.09.010 – volume: 152 start-page: 880 year: 2017 ident: ref_96 article-title: Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.11.042 – volume: 17 start-page: 773 year: 2020 ident: ref_30 article-title: Comparing Breast Abdominal Subspecialists’ Follow-Up Recommendations for Incidental Liver Lesions on Breast MRI publication-title: J. Am. Coll. Radiol. doi: 10.1016/j.jacr.2019.12.024 – volume: 37 start-page: 854 year: 2011 ident: ref_47 article-title: Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: A meta-analysis publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2011.03.006 – volume: 49 start-page: 1780 year: 2023 ident: ref_111 article-title: Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2023.03.026 – volume: 305 start-page: 721 year: 2022 ident: ref_82 article-title: A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions publication-title: Radiology doi: 10.1148/radiol.212317 – volume: 90 start-page: 699 year: 2010 ident: ref_21 article-title: Management of an incidental liver mass publication-title: Surg. Clin. N. Am. doi: 10.1016/j.suc.2010.04.005 – volume: 6 start-page: 643 year: 1990 ident: ref_12 article-title: Abdominal sonographic screening in a single community publication-title: Gaoxiong Yi Xue Ke Xue Za Zhi – volume: 123 start-page: 119 year: 1998 ident: ref_13 article-title: Ultrasound in diagnosis of benign and malignant liver tumors publication-title: Zentralbl. Chir. – volume: 45 start-page: 1 year: 2019 ident: ref_99 article-title: Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2018.06.015 – volume: 12 start-page: 1414 year: 2014 ident: ref_34 article-title: Liver masses: A clinical, radiologic, and pathologic perspective publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2013.09.017 – volume: 14 start-page: 1429 year: 2017 ident: ref_11 article-title: Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee publication-title: J. Am. Coll. Radiol. doi: 10.1016/j.jacr.2017.07.018 – volume: 101 start-page: 106716 year: 2023 ident: ref_59 article-title: Ultrasound tissue scatterer distribution imaging: An adjunctive diagnostic tool for shear wave elastography in characterizing focal liver lesions publication-title: Ultrason Sonochem. doi: 10.1016/j.ultsonch.2023.106716 – volume: 69 start-page: 1382 year: 2020 ident: ref_73 article-title: Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology publication-title: Gut doi: 10.1136/gutjnl-2020-321299 – volume: 33 start-page: E241 year: 2012 ident: ref_95 article-title: Imaging features of intrahepatic biliary cystadenoma and cystadenocarcinoma on B-mode and contrast-enhanced ultrasound publication-title: Ultraschall Med. doi: 10.1055/s-0031-1299276 – volume: 25 start-page: 335 year: 2019 ident: ref_17 article-title: Detect or not to detect very early stage hepatocellular carcinoma? The western perspective publication-title: Clin. Mol. Hepatol. doi: 10.3350/cmh.2019.0010 – volume: 50 start-page: 355 year: 2015 ident: ref_35 article-title: Diagnostic workup of liver lesions: Too long time with too many examinations publication-title: Scand J. Gastroenterol. doi: 10.3109/00365521.2014.999349 – volume: 39 start-page: 1149 year: 2019 ident: ref_25 article-title: Incidence and characteristics of benign liver space-occupying mass in 17 721 patients with chronic hepatitis B: A color Doppler ultrasound-based case-control study publication-title: Nan Fang Yi Ke Da Xue Xue Bao – volume: 14 start-page: 324 year: 2017 ident: ref_29 article-title: Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial publication-title: J. Am. Coll. Radiol. doi: 10.1016/j.jacr.2016.09.044 – volume: 25 start-page: 1494 year: 2021 ident: ref_101 article-title: Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons’ Perspective publication-title: J. Gastrointest. Surg. doi: 10.1007/s11605-020-04724-1 – volume: 11 start-page: 6354 year: 2005 ident: ref_109 article-title: Imaging findings of biliary hamartomas publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v11.i40.6354 – volume: 48 start-page: 2355 year: 2022 ident: ref_7 article-title: Incidental Findings of Gallbladder and Bile Ducts-Management Strategies: General Aspects, Gallbladder Polyps and Gallbladder Wall Thickening-A World Federation of Ultrasound in Medicine and Biology (WFUMB) Position Paper publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2022.06.016 – volume: 30 start-page: 3497 year: 2020 ident: ref_125 article-title: Hepatocellular adenomas: Is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? publication-title: Eur. Radiol. doi: 10.1007/s00330-020-06726-8 – volume: 31 start-page: 283 year: 2010 ident: ref_19 article-title: Indeterminate, subcentimetric focal liver lesions in cancer patients: Additional role of contrast-enhanced ultrasound publication-title: Ultraschall Med. doi: 10.1055/s-0029-1245383 – volume: 30 start-page: 2995 year: 2020 ident: ref_115 article-title: Liver contrast-enhanced sonography: Computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns publication-title: Eur. Radiol. doi: 10.1007/s00330-019-06566-1 – volume: 8 start-page: e000592 year: 2021 ident: ref_97 article-title: Scoping review of clinical practice guidelines on the management of benign liver tumours publication-title: BMJ Open Gastroenterol. doi: 10.1136/bmjgast-2020-000592 – volume: 40 start-page: 1529 year: 2020 ident: ref_131 article-title: New insights in the management of Hepatocellular Adenoma publication-title: Liver Int. doi: 10.1111/liv.14547 – volume: 37 start-page: 1178 year: 2002 ident: ref_23 article-title: The value of routinely performed ultrasonography in patients with Crohn disease publication-title: Scand J. Gastroenterol. doi: 10.1080/003655202760373399 – volume: 109 start-page: 1328 year: 2014 ident: ref_74 article-title: ACG clinical guideline: The diagnosis and management of focal liver lesions publication-title: Am. J. Gastroenterol. doi: 10.1038/ajg.2014.213 – volume: 35 start-page: 925 year: 2020 ident: ref_36 article-title: The effects of incidental findings from whole-body MRI on the frequency of biopsies and detected malignancies or benign conditions in a general population cohort study publication-title: Eur. J. Epidemiol. doi: 10.1007/s10654-020-00679-4 – volume: 25 start-page: 435 year: 2023 ident: ref_118 article-title: Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesions—Non-infectious, non-neoplastic publication-title: Med. Ultrason. doi: 10.11152/mu-4192 – volume: 33 start-page: 739 year: 2013 ident: ref_41 article-title: Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: A meta-analysis publication-title: Liver Int. doi: 10.1111/liv.12115 – volume: 57 start-page: 270 year: 2017 ident: ref_10 article-title: Incidental findings of liver, biliary system, pancreas and spleen in asymptomatic patients: Assessment and management recommendations publication-title: Radiologe doi: 10.1007/s00117-017-0235-x – volume: 128 start-page: 109027 year: 2020 ident: ref_130 article-title: Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas publication-title: Eur. J. Radiol. doi: 10.1016/j.ejrad.2020.109027 – volume: 46 start-page: 1815 year: 2020 ident: ref_1 article-title: Commentary on the World Federation for Ultrasound in Medicine and Biology Project “Incidental Findings” publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2020.02.002 – volume: 52 start-page: 47 year: 2015 ident: ref_123 article-title: Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations publication-title: Arq. Gastroenterol. doi: 10.1590/s0004-28032015000500003 – volume: 43 start-page: 2144 year: 2017 ident: ref_114 article-title: A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound publication-title: Ultrasound Med. Biol. doi: 10.1016/j.ultrasmedbio.2017.05.011 |
SSID | ssj0000331767 |
Score | 2.3588445 |
SecondaryResourceType | review_article |
Snippet | An incidental focal liver lesion (IFLL) is defined as a hepatic lesion identified in a patient imaged for an unrelated reason. They are frequently encountered... This review paper deals with incidentally found focal liver lesions (IFLLs) in otherwise healthy subjects, which is a frequent occurrence in daily practice.... Simple SummaryThis review paper deals with incidentally found focal liver lesions (IFLLs) in otherwise healthy subjects, which is a frequent occurrence in... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2908 |
SubjectTerms | Asymptomatic Benign Biopsy Calcification Care and treatment Cirrhosis Contrast agents Diagnosis Hemangioma Lesions Liver cancer Liver cirrhosis Liver diseases Malignancy Parenchyma Patients Review Risk factors Risk groups Ultrasonic imaging Ultrasound |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS-QwEB-8FeReRD311i8iHJwPVrfNtk19ERWX5bj1RFwUfChpknIL0q7bFfG_d6bN1q2gz5mUNJmP30wmMwC_0Ogk6P1LB21VgA6K5k7iBb7jauToxDUi1BTvGFwF_WH3z71_bwNuhU2rnOnEUlHrXFGM_JiXDw6o_vrp-MmhrlF0u2pbaHyDRVTBwm_B4vnl1fVNHWXpcLSPQVjV9OHo3x8r2sxJgUAn8CJqKjlnjj4q5Tmr1MyYnDNBvRVYttiRnVWHvQoLJluDpYG9Hf8BD3e94eCcVeF-di3HZnLEUAFQ31DE2Kw3Kp-wFGyUsX8E_F5GhWHVQ6RXhiqEYjLFIevnL2yasyoz5oT9pdSNdRj2Lm8v-o5tnuCoroimjjR-mCYJwjMVmhRNoR-l2nc5_jaKpG-04EFEaETpLlKg2EuZBEKjuVaRRNd1A1pZnpmfwEwacZHiXCNEV6WB7CS-DtNOSi3LFJdtOJrtYaxsZXFqcPEYo4dBmx5_2PQ2HNQTxlVRjc9Jf9OhxCRu-E0l7asBXBkVrorPqJiPR22z27DToEQxUc3h2bHGVkyL-J2p2rBfD9NMSj3LTP5c0kQuublIs1lxQb1oHlESd4gfFw3-qAmoeHdzJBv9L4t4uy5C3zAUW1-vaxu-ewijKIrtuTvQmk6ezS7CoGmyZ3n9DbJ5B_8 priority: 102 providerName: ProQuest |
Title | WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39199678 https://www.proquest.com/docview/3097830875 https://www.proquest.com/docview/3099141565 https://pubmed.ncbi.nlm.nih.gov/PMC11352778 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_WFkZfRvfVZu2CBoPtYU7jL1kejNGOZmEsXRkLC_TByLLMAsHp4pSu__1-ZztZXdo96yTk8-l-d9J9EL0G6KTw_rUDrJJwUDLfST0ZOm4GiU5dq6KM7ztGp3I4Dr5Mwsm_dkANA8s7XTvuJzVezHp_fl9_xIH_wB4nXPZDw_xZlLBdpBdz4u8WYEmyiI8aW79Syz6gsuoo6_Ujz5EyDupSP3et0UKp27r6Bli1AylvINNghx41JqU4qmXgMT2wxRN6OGoezZ_S-c_BeHQs6lcAcaYv7KInoBe4nSi-WgymVWZLKaaF-Mb24NW0tKLOT7oW0Cx8VVO-E8P5lVjORR0w81585YiOZzQenPz4NHSangqOCVS8dLQNozxNYbWZyOZAyDDOs9D18dk4qaHNlA_GwEgxWQAKaAOtU6kyoLiJNTza57RZzAu7R8Lmsa9yzLVKBSaXup-GWZT3c-5kZnzdod6Kh4lpCo5z34tZAseDmZ7cYnqH3q4nXNS1Nu4nfcM_JWG5wJpGN8kE2BnXs0qOuMaPx920O3TQosTpMe3h1W9NVsKX-FVyC9f679Cr9TDP5Ii0ws4vK5rYZe8XNLu1FKw37ccc2x1hcdWSjzUB1_RujxTTX1Vtb9eFRRxF6sX_t71P2x6sK77c9twD2lwuLu1LWEfLtEtbxyenZ9-7tPF54narM_AXHasOkw |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTQJe0Phc2QAjgeCBbE3cODYSQhus6lhbJrRqk3jIHMcRlVBSmk7V_in-Ru7yRTMJ3vbss2XZd_e7s-8D4BWCToTev3YQqwQ6KDF3Ik_4jhsjR0eulUFM7x2jsRhMel_O_fM1-F3nwlBYZa0TC0UdZ4beyPd4kXBA9dc_zn451DWKflfrFholWxzbqyW6bPmHo894v689r394-mngVF0FHNOTauFo6wdJFKHdYgKbIEb4Kol9l7vCQ171bSy5UATTJu4hBcqD1pGQMeKYURp9Olz3FmygmaFQijYODscn35pXnS5HPBZBWUOIc9XdM3R58xwNK-EpamK5An_XQWAFBdsRmiuQ19-Ee5WtyvZL5roPazZ9ALdH1W_8Q_h-1p-MDlj5vcBO9MzOdxkqHOpTijY960-LlJmcTVP2lQzN5TS3rEx8umKosugNKH_HBtmSLTJWRuK8Z0MKFXkEkxs51sewnmap3QJmE8VlgnOtlD2TCN2N_DhIugm1SDNcd2C3PsPQVJXMqaHGzxA9Gjr08Nqhd-BtM2FWFvH4N-kbupSQxBvXNLrKUsCdUaGscJ-KB3nUprsDOy1KFEvTHq6vNazUQh7-ZeIOvGyGaSaFuqU2uyxolEtuNdI8Kbmg2TRXFDQe4OKyxR8NARULb4-k0x9F0XDXRVM7COTT_-_rBdwZnI6G4fBofLwNdz004egF3XN3YH0xv7TP0ARbRM8rvmdwcdOi9geldUVc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTpp4QWx8FTZmJBA8kLWJm9hGQmhjizq2lgpRbRIPIXEcUQklpelU7V_jr-MuXzST4G3PPluWfXe_O_s-AF4i6ETo_YcWYpWHDkrMrcjxXMuOkaMj20gR03vHaOwNp4NPl-7lBvyuc2EorLLWiYWijjNNb-Q9XiQcUP31XlKFRUyO_Q_zXxZ1kKKf1rqdRskiZ-Z6he5b_v70GO_6leP4J18_Dq2qw4ClB1ItrdC4IokitGG0MAnihauS2LW57TnIt66JJfcUQbaOB0iBshGGkSdjxDStQvTvcN07sCkQFWUHNo9OxpMvzQtPnyM2e6KsJ8S56vc0XeQiRyPLcxQ1tFyDwpuAsIaI7WjNNfjz78O9ym5lhyWjbcOGSXdga1T9zD-Abxf-dHTEyq8GNgnnZnHAUPlQz1K075k_K9JncjZL2WcyOlez3LAyCeqaofqi96D8LRtmK7bMWBmV846dU9jIQ5jeyrE-gk6apeYJMJMoLhOca6Qc6MQL-5Ebi6SfULs0zcMuHNRnGOiqqjk11_gZoHdDhx7cOPQuvGkmzMuCHv8mfU2XEpCo45o6rDIWcGdUNCs4pEJCDrXs7sJuixJFVLeH62sNKhWRB38ZugsvmmGaSWFvqcmuChplk4uNNI9LLmg2zRUFkAtcXLb4oyGgwuHtkXT2oyggbttodgshn_5_X_uwhSIWnJ-Oz57BXQetOXpMd-xd6CwXV2YPrbFl9Lxiewbfb1vS_gCEjkmI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=WFUMB+Review+Paper.+Incidental+Findings+in+Otherwise+Healthy+Subjects%2C+How+to+Manage%3A+Liver&rft.jtitle=Cancers&rft.au=%C8%98irli%2C+Roxana&rft.au=Popescu%2C+Alina&rft.au=Jenssen%2C+Christian&rft.au=M%C3%B6ller%2C+Kathleen&rft.date=2024-08-21&rft.pub=MDPI+AG&rft.issn=2072-6694&rft.eissn=2072-6694&rft.volume=16&rft.issue=16&rft_id=info:doi/10.3390%2Fcancers16162908&rft.externalDocID=A807424408 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon |